Document is current
Any future updates will be listed below
-
Authors
Zheng, Chunxing https://orcid.org/0000-0002-8668-0873
Liu, Shaofeng
Fazel Modares, Nastaran
St. Paul, Michael https://orcid.org/0000-0002-5213-6415
Mak, Tak W. https://orcid.org/0000-0001-6766-861X
-
Funding
Funding for this research was provided by:
Gouvernement du Canada | Canadian Institutes of Health Research
Cancer Research Institute
- License Information
-
More Information
Article History
Received: 31 August 2024
Accepted: 6 March 2025
First Online: 30 April 2025
Competing interests
: T.W.M. owns equity in Treadwell Therapeutics and is a consultant for AstraZeneca. All other authors declare no competing interests.
